12h
Hosted on MSNKaiser clears 1,000 patients of Hepatitis CConsidered once to be a lifelong disease, Hepatitis C has now been treated and cured in 1,000 patients at Kaiser Permanente.
Stage 4 – ‘e’-antigen-negative chronic active hepatitis: Some people move from stage 3 to stage 4 when their hepatitis B virus mutates to escape antibody control. People in this stage lack ‘e’-antigen ...
Hawaii’s Kaiser Permanente Viral Hepatitis Clinic has reached a major milestone toward combative Hepatitis outcomes. On ...
A multicenter, prospective observational study of chemotherapy in elderly patients with biliary tract cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.
Savage resident Edwin Tan spent his summer carrying a message across the triathlon finish line. Tan, 29, lives with chronic hepatitis B. He said there isn’t a lot of public ...
GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...
Infection with hepatitis B virus can have serious consequences including acute massive hepatic necrosis and chronic active hepatitis. Antibody concentrations ≥10mIU/mL against HBsAg are ...
A new study published in the journal of Nature Scientific Reports found that anemia was almost three times as common in women ...
Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).
Chronic hepatitis B (CHB) remains a significant global health challenge, and effective antiviral therapies are essential for long-term management. This study aimed to evaluate the real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results